Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Disease Control and Environmental Health, Makerere University, Kampala, Uganda.
Lancet Infect Dis. 2013 Dec;13(12):1021-8. doi: 10.1016/S1473-3099(13)70226-3. Epub 2013 Oct 17.
Scarce data are available to assess sexual behaviour of individuals using antiretroviral pre-exposure prophylaxis for HIV prevention. Increased sexual risk taking by individuals using effective HIV prevention strategies, like pre-exposure prophylaxis, could offset the benefits of HIV prevention. We studied whether the use of pre-exposure prophylaxis in HIV-uninfected men and women in HIV-serodiscordant couples was associated with increased sexual risk behaviour.
We undertook a longitudinal analysis of data from the Partners PrEP Study, a double-blind, randomised, placebo-controlled trial of daily oral pre-exposure prophylaxis among HIV-uninfected partners of heterosexual HIV-serodiscordant couples (n=3163, ≥18 years of age). Efficacy for HIV prevention was publicly reported in July 2011, and participants continued monthly follow-up thereafter. We used regression analyses to compare the frequency of sex-unprotected by a condom-during the 12 months after compared with the 12 months before July 2011, to assess whether knowledge of pre-exposure prophylaxis efficacy for HIV prevention caused increased sexual risk behaviour.
We analysed 56 132 person-months from 3024 HIV-uninfected individuals (64% male). The average frequency of unprotected sex with the HIV-infected study partner was 59 per 100 person-months before unmasking versus 53 after unmasking; we recorded no immediate change (p=0·66) or change over time (p=0·25) after July, 2011. We identified a significant increase in unprotected sex with outside partners after July, 2011, but the effect was small (average of 6·8 unprotected sex acts per year vs 6·2 acts in a predicted counterfactual scenario had patients remained masked, p=0·04). Compared with before July, 2011, we noted no significant increase in incident sexually transmitted infections or pregnancy after July, 2011.
Pre-exposure prophylaxis, provided as part of a comprehensive prevention package, might not result in substantial changes in risk-taking sexual behaviour by heterosexual couples.
The Bill & Melinda Gates Foundation and the US National Institute of Mental Health.
评估使用抗逆转录病毒药物进行艾滋病毒预防的个体性行为的相关数据十分有限。使用有效的艾滋病毒预防策略(如暴露前预防)的个体发生性行为的风险增加,可能会抵消艾滋病毒预防的益处。我们研究了在艾滋病毒血清不一致的夫妇中,感染艾滋病毒的男性和女性使用暴露前预防是否与性行为风险增加有关。
我们对来自 Partners PrEP 研究的数据进行了纵向分析,这是一项针对艾滋病毒血清不一致的异性恋夫妇中未感染艾滋病毒的伴侣(n=3163,年龄≥18 岁)每日口服暴露前预防的双盲、随机、安慰剂对照试验。2011 年 7 月公布了艾滋病毒预防效果,此后参与者继续每月随访。我们使用回归分析比较了 2011 年 7 月之前和之后 12 个月内未使用避孕套进行性行为的频率,以评估对艾滋病毒预防暴露前预防效果的了解是否导致性行为风险增加。
我们分析了 3024 名未感染艾滋病毒的个体(64%为男性)的 56132 人-月。在未揭开真相前,艾滋病毒感染者研究伴侣的无保护性行为的平均频率为每 100 人-月 59 次,揭开真相后为每 100 人-月 53 次;我们没有发现 7 月 2011 日之后立即发生变化(p=0·66)或随着时间的推移发生变化(p=0·25)。我们发现,2011 年 7 月之后,与外部伴侣发生无保护性行为的人数显著增加,但影响很小(如果患者继续保持蒙在鼓里,预计每年会有 6·8 次无保护性行为,而实际发生了 6·2 次,p=0·04)。与 2011 年 7 月之前相比,我们没有发现 2011 年 7 月之后性传播感染或怀孕的发生率显著增加。
暴露前预防作为综合预防方案的一部分,可能不会导致异性恋夫妇的风险性行为发生实质性变化。
比尔和梅琳达·盖茨基金会和美国国家心理健康研究所。